KORU Medical Systems (NASDAQ:KRMD - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.04) by $0.02, Zacks reports. KORU Medical Systems had a negative net margin of 48.18% and a negative return on equity of 27.82%. The company had revenue of $8.20 million for the quarter, compared to the consensus estimate of $7.49 million. During the same quarter in the prior year, the firm earned ($0.05) earnings per share.
KORU Medical Systems Trading Up 5.8 %
Shares of NASDAQ KRMD traded up $0.13 during midday trading on Thursday, hitting $2.38. The company's stock had a trading volume of 90,707 shares, compared to its average volume of 96,461. KORU Medical Systems has a 12-month low of $1.98 and a 12-month high of $4.30. The company has a current ratio of 4.55, a quick ratio of 3.77 and a debt-to-equity ratio of 0.02. The firm has a market cap of $108.79 million, a P/E ratio of -8.21 and a beta of 0.56. The business's 50 day moving average is $2.19 and its two-hundred day moving average is $2.24.
Analyst Upgrades and Downgrades
Separately, B. Riley reaffirmed a "buy" rating and issued a $4.00 price target on shares of KORU Medical Systems in a report on Thursday, March 14th.
Get Our Latest Analysis on KRMD
About KORU Medical Systems
(
Get Free Report)
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider KORU Medical Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KORU Medical Systems wasn't on the list.
While KORU Medical Systems currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
